vs
Side-by-side financial comparison of GE HealthCare (GEHC) and Vertiv Holdings Co (VRT). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.1B vs $2.6B, roughly 1.9× Vertiv Holdings Co). Vertiv Holdings Co runs the higher net margin — 14.7% vs 8.0%, a 6.7% gap on every dollar of revenue. On growth, Vertiv Holdings Co posted the faster year-over-year revenue change (30.1% vs 7.4%). Vertiv Holdings Co produced more free cash flow last quarter ($652.8M vs $112.0M). Over the past eight quarters, Vertiv Holdings Co's revenue compounded faster (16.5% CAGR vs 3.0%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
Vertiv is an American multinational provider of critical infrastructure and services for data centers, communication networks, and commercial and industrial environments.
GEHC vs VRT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.1B | $2.6B |
| Net Profit | $411.0M | $390.1M |
| Gross Margin | 38.5% | 37.7% |
| Operating Margin | 10.0% | — |
| Net Margin | 8.0% | 14.7% |
| Revenue YoY | 7.4% | 30.1% |
| Net Profit YoY | -31.0% | — |
| EPS (diluted) | $0.85 | $0.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $5.1B | $2.6B | ||
| Q4 25 | $5.7B | $2.9B | ||
| Q3 25 | $5.1B | $2.7B | ||
| Q2 25 | $5.0B | $2.6B | ||
| Q1 25 | $4.8B | $2.0B | ||
| Q4 24 | $5.3B | $2.3B | ||
| Q3 24 | $4.9B | $2.1B | ||
| Q2 24 | $4.8B | $2.0B |
| Q1 26 | $411.0M | $390.1M | ||
| Q4 25 | $588.0M | $445.6M | ||
| Q3 25 | $446.0M | $398.5M | ||
| Q2 25 | $486.0M | $324.2M | ||
| Q1 25 | $564.0M | $164.5M | ||
| Q4 24 | $721.0M | $147.0M | ||
| Q3 24 | $470.0M | $176.6M | ||
| Q2 24 | $428.0M | $178.1M |
| Q1 26 | 38.5% | 37.7% | ||
| Q4 25 | 39.7% | 38.9% | ||
| Q3 25 | 38.7% | 37.8% | ||
| Q2 25 | 39.6% | 34.0% | ||
| Q1 25 | 42.1% | 33.7% | ||
| Q4 24 | 42.8% | 37.1% | ||
| Q3 24 | 41.7% | 36.5% | ||
| Q2 24 | 41.4% | 38.0% |
| Q1 26 | 10.0% | — | ||
| Q4 25 | 14.5% | 20.1% | ||
| Q3 25 | 12.7% | 19.3% | ||
| Q2 25 | 13.1% | 16.8% | ||
| Q1 25 | 13.2% | 14.3% | ||
| Q4 24 | 15.1% | 19.5% | ||
| Q3 24 | 13.9% | 17.9% | ||
| Q2 24 | 12.6% | 17.2% |
| Q1 26 | 8.0% | 14.7% | ||
| Q4 25 | 10.3% | 15.5% | ||
| Q3 25 | 8.7% | 14.9% | ||
| Q2 25 | 9.7% | 12.3% | ||
| Q1 25 | 11.8% | 8.1% | ||
| Q4 24 | 13.6% | 6.3% | ||
| Q3 24 | 9.7% | 8.5% | ||
| Q2 24 | 8.8% | 9.1% |
| Q1 26 | $0.85 | $0.99 | ||
| Q4 25 | $1.28 | $1.14 | ||
| Q3 25 | $0.98 | $1.02 | ||
| Q2 25 | $1.06 | $0.83 | ||
| Q1 25 | $1.23 | $0.42 | ||
| Q4 24 | $1.58 | $0.38 | ||
| Q3 24 | $1.02 | $0.46 | ||
| Q2 24 | $0.93 | $0.46 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $2.5B |
| Total DebtLower is stronger | $10.1B | $0 |
| Stockholders' EquityBook value | $10.7B | $4.2B |
| Total Assets | $37.1B | $13.4B |
| Debt / EquityLower = less leverage | 0.95× | 0.00× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $2.5B | ||
| Q4 25 | $4.5B | $1.7B | ||
| Q3 25 | $4.0B | $1.4B | ||
| Q2 25 | $3.7B | $1.6B | ||
| Q1 25 | $2.5B | $1.5B | ||
| Q4 24 | $2.9B | $1.2B | ||
| Q3 24 | $3.5B | $908.7M | ||
| Q2 24 | $2.0B | $579.7M |
| Q1 26 | $10.1B | $0 | ||
| Q4 25 | $10.0B | $2.9B | ||
| Q3 25 | $10.3B | $2.9B | ||
| Q2 25 | $10.3B | $2.9B | ||
| Q1 25 | $8.8B | $2.9B | ||
| Q4 24 | $9.0B | $2.9B | ||
| Q3 24 | $10.3B | $2.9B | ||
| Q2 24 | $9.2B | $2.9B |
| Q1 26 | $10.7B | $4.2B | ||
| Q4 25 | $10.4B | $3.9B | ||
| Q3 25 | $10.0B | $3.5B | ||
| Q2 25 | $9.7B | $3.1B | ||
| Q1 25 | $9.2B | $2.7B | ||
| Q4 24 | $8.4B | $2.4B | ||
| Q3 24 | $8.3B | $1.8B | ||
| Q2 24 | $7.8B | $1.5B |
| Q1 26 | $37.1B | $13.4B | ||
| Q4 25 | $36.9B | $12.2B | ||
| Q3 25 | $36.1B | $10.8B | ||
| Q2 25 | $35.5B | $10.4B | ||
| Q1 25 | $33.6B | $9.5B | ||
| Q4 24 | $33.1B | $9.1B | ||
| Q3 24 | $33.9B | $8.9B | ||
| Q2 24 | $31.9B | $8.1B |
| Q1 26 | 0.95× | 0.00× | ||
| Q4 25 | 0.96× | 0.74× | ||
| Q3 25 | 1.03× | 0.83× | ||
| Q2 25 | 1.06× | 0.93× | ||
| Q1 25 | 0.95× | 1.10× | ||
| Q4 24 | 1.06× | 1.20× | ||
| Q3 24 | 1.24× | 1.62× | ||
| Q2 24 | 1.18× | 1.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | $112.0M | $652.8M |
| FCF MarginFCF / Revenue | 2.2% | 24.6% |
| Capex IntensityCapex / Revenue | — | 4.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $978.9M | ||
| Q3 25 | — | $508.7M | ||
| Q2 25 | $94.0M | $322.9M | ||
| Q1 25 | $250.0M | $303.3M | ||
| Q4 24 | — | $425.2M | ||
| Q3 24 | — | $378.2M | ||
| Q2 24 | $-119.0M | $378.4M |
| Q1 26 | $112.0M | $652.8M | ||
| Q4 25 | — | $885.6M | ||
| Q3 25 | — | $463.5M | ||
| Q2 25 | $8.0M | $277.9M | ||
| Q1 25 | $98.0M | $266.8M | ||
| Q4 24 | — | $364.5M | ||
| Q3 24 | — | $341.8M | ||
| Q2 24 | $-183.0M | $344.3M |
| Q1 26 | 2.2% | 24.6% | ||
| Q4 25 | — | 30.8% | ||
| Q3 25 | — | 17.3% | ||
| Q2 25 | 0.2% | 10.5% | ||
| Q1 25 | 2.1% | 13.1% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 16.5% | ||
| Q2 24 | -3.8% | 17.6% |
| Q1 26 | — | 4.2% | ||
| Q4 25 | 2.4% | 3.2% | ||
| Q3 25 | 2.1% | 1.7% | ||
| Q2 25 | 1.7% | 1.7% | ||
| Q1 25 | 3.2% | 1.8% | ||
| Q4 24 | 1.9% | 2.6% | ||
| Q3 24 | 1.9% | 1.8% | ||
| Q2 24 | 1.3% | 1.7% |
| Q1 26 | — | — | ||
| Q4 25 | — | 2.20× | ||
| Q3 25 | — | 1.28× | ||
| Q2 25 | 0.19× | 1.00× | ||
| Q1 25 | 0.44× | 1.84× | ||
| Q4 24 | — | 2.89× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | -0.28× | 2.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging revenues | $2.3B | 45% |
| AVS revenues | $1.3B | 26% |
| PDx revenues | $770.0M | 15% |
| PCS revenues | $704.0M | 14% |
| Other revenues | $18.0M | 0% |
VRT
Segment breakdown not available.
